Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GAMMA Study: Patient Self-testing of Capillary Blood Potassium: A Validation Study and Measurement Performance in Patients.

NCT05975632 is registered in ClinicalTrials.gov with CardioRenal as lead sponsor.

NCT NCT05975632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05975632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GAMMA Study: Patient Self-testing of Capillary Blood Potassium: A Validation Study and Measurement Performance in Patients.
Lead sponsor
CardioRenal
Phase
Not applicable
Overall status
Unknown status
Start date
August 2, 2023
Completion date
March 31, 2024
Enrollment
300 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

potassium measurement